Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system
(CNS) and the most common non-traumatic cause of neurological disability in young adults …

Objectives To update the knowledge on the occupational outcomes associated with multiple
sclerosis (MS), systematically examine the extent, scope and nature of the pre-existing …

Objectives: To analyze work productivity loss and costs, including absenteeism (time missed
from work), presenteeism (reduced productivity while working), and unpaid work loss …

Background Cognitive impairment is a common symptom of multiple sclerosis (MS). The
effect of cognitive impairment in people with MS on employment, quality of life and mental …

Background: The MS disease-modifying therapies (DMTs) prescribing landscape in
Australia have changed over time. Objectives: This study evaluated the utilisation and cost …

Introduction In light of the increasing number of economic burden studies and heterogeneity
in methodology and reporting standards, there is a need for robust evidence synthesis on an …

Background Due to the high and increasing economic burden of chronic diseases, including
Multiple sclerosis (MS), we aimed to investigate the medical cost of MS in Iran. Methods This …

Introduction Multiple sclerosis (MS) causes a wide variety of symptoms. Loss of income due
to sickness and early retirement comprise one-third of the total cost of MS in Australia. An …

Cognitive impairment in multiple sclerosis (MS) affects approximately 40–70% of patients
and can have varying degrees of severity. Even mild cognitive impairment can impact on …

Background Multiple sclerosis (MS) is a chronic autoimmune/neurodegenerative disease
associated with progressing disability affecting mostly women. We aim to estimate transition …